Literature DB >> 11948361

Global epidemiology and medical aspects of hepatitis E.

K Krawczynski1, S Kamili, R Aggarwal.   

Abstract

Hepatitis E is a self-limited enterically transmitted acute viral hepatitis that occurs frequently in epidemic outbreaks and as sporadic hepatitis in the Indian sub-continent, Southeast and Central Asia, the Middle East, parts of Africa, and Mexico. Hepatitis E virus (HEV) is excreted in faeces and is transmitted predominantly by the faecal-oral route, usually through contaminated water. The reservoir of the virus during the inter-epidemic periods in disease-endemic countries may reside in the environment, in sub-clinically HEV-infected humans, and/or animals infected with an HEV-like virus. Chronic infection is unknown. Diagnosis of HEV infection is usually made by detection of anti-HEV antibodies or HEV-RNA in patients serum specimens. Clinical illness due to HEV infection is similar to other forms of viral hepatitis except in pregnant women, in whom the illness is particularly severe with a mortality as high as 25%. Asymptomatic and anicteric infections may occur. No specific treatment is available, and the most effective mode of preventing this disease is use of clean water and proper sanitation. Recombinant vaccines are being developed that may be particularly useful for travellers to the disease-endemic areas and for pregnant women.

Entities:  

Mesh:

Year:  2001        PMID: 11948361

Source DB:  PubMed          Journal:  Forum (Genova)        ISSN: 1121-8142


  8 in total

1.  In vitro and in vivo mutational analysis of the 3'-terminal regions of hepatitis e virus genomes and replicons.

Authors:  Judith Graff; Hanh Nguyen; Chaiyan Kasorndorkbua; Patrick G Halbur; Marisa St Claire; Robert H Purcell; Suzanne U Emerson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Disparities in detection of antibodies against hepatitis E virus in US blood donor samples using commercial assays.

Authors:  Mohammad Zafrullah; Xiugen Zhang; Coleen Tran; Megan Nguyen; Saleem Kamili; Michael A Purdy; Susan L Stramer
Journal:  Transfusion       Date:  2018-03-09       Impact factor: 3.157

3.  Hepatitis E: a complex and global disease.

Authors:  E Pelosi; I Clarke
Journal:  Emerg Health Threats J       Date:  2008-11-07

4.  Population Movement and Virus Spreading: HEV Spreading in a Pilgrimage City, Mashhad in Northeast Iran; an Example.

Authors:  Sanaz Ahmadi Ghezeldasht; Rahele Miri; Mohamadreza Hedayatimoghadam; Aliakbar Shamsian; Hamidreza Bidkhori; Fahad Fathimoghadam; Seyyed Abdorrahim Rezaee
Journal:  Hepat Mon       Date:  2013-08-04       Impact factor: 0.660

5.  A Single Lineage of Hepatitis E Virus Causes Both  Outbreaks and Sporadic Hepatitis in Sudan.

Authors:  Adel Hussein Elduma; Mai Mohammed Adam Zein; Marie Karlsson; Isam M E Elkhidir; Heléne Norder
Journal:  Viruses       Date:  2016-10-06       Impact factor: 5.048

Review 6.  Viral hepatitis in pregnancy.

Authors:  Mohamed Tarek M Shata; Helal F Hetta; Yeshika Sharma; Kenneth E Sherman
Journal:  J Viral Hepat       Date:  2022-07-07       Impact factor: 3.517

7.  Hepatitis E virus genotype 4, Nanjing, China, 2001-2011.

Authors:  Xing Dai; Chen Dong; Zhenxian Zhou; Jiuhong Liang; Min Dong; Yan Yang; Jianguang Fu; Hua Tian; Song Wang; Jie Fan; Jihong Meng; Michael A Purdy
Journal:  Emerg Infect Dis       Date:  2013       Impact factor: 6.883

8.  Effective inhibition of hepatitis E virus replication in A549 cells and piglets by RNA interference (RNAi) targeting RNA-dependent RNA polymerase.

Authors:  Fen Huang; Xiuguo Hua; Shixing Yang; Congli Yuan; Wen Zhang
Journal:  Antiviral Res       Date:  2009-07-01       Impact factor: 5.970

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.